We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

NOV 15 2023

Understanding The FDA's Current Focus On Risk Evaluation And Mitigation Strategies – Life Sciences Connect

Linda Pissott Reig, shareholder in the firm's FDA/Biotech and Life Sciences practice groups, was featured in an interview with Life Sciences Connect publications about the REMS Industry Consortium (RIC) comment to the FDA on the future of risk evaluation and mitigation strategies. Linda and Buchanan serve as legal counsel and strategic partner to the RIC.

Read the Q&A here.